class name | count |
---|---|
asterids | 7 |
Liliopsida | 1 |
rosids | 1 |
class name | count |
---|---|
Sapotaceae | 2 |
Enterobacteriaceae | 2 |
Orobanchaceae | 1 |
Boletaceae | 1 |
Streptomycetaceae | 1 |
Cornaceae | 1 |
Asteraceae | 1 |
Aspergillaceae | 1 |
Orchidaceae | 1 |
Lamiaceae | 1 |
Rosaceae | 1 |
Valsaceae | 1 |
Hymenochaetaceae | 1 |
Rubiaceae | 1 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00000143
![]() |
3-Hydroxyuridine
|
![]() |
||||
C00016743
![]() |
NSC 518132
/ Thiouridine / 4-Thiouridine |
CHEMBL390500
CHEMBL1330220 |
D013891
|
5 / 2 / 1 | 0 / 1 |
![]() |
C00019674
![]() |
Uridine
|
CHEMBL68846
CHEMBL100259 CHEMBL265701 CHEMBL608294 CHEMBL609651 CHEMBL1092065 CHEMBL2093066 |
D014529
|
5 / 0 / 3 | 7 / 15 |
![]() |
C00033569
![]() |
4-Selenouridine
|
![]() |
||||
C00042440
![]() |
Cytidine
|
CHEMBL6592
CHEMBL78 CHEMBL803 CHEMBL95606 CHEMBL1315342 CHEMBL2028065 CHEMBL2092816 CHEMBL2093067 |
D003562
|
115 / 62 / 54 | 2 / 1 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
O75496 | Geminin | Unclassified protein | C00016743 C00019674 C00042440 | 0 / 0 |
Q9HA47 | Uridine-cytidine kinase 1 | Enzyme | C00019674 C00042440 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00019674 C00042440 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00016743 C00042440 | 1 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00019674 C00042440 | 0 / 3 |
P03372 | Estrogen receptor | NR3A1 | C00042440 | 1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00042440 | 0 / 0 |
Q15788 | Nuclear receptor coactivator 1 | Enzyme | C00042440 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00042440 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00042440 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00042440 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00042440 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00042440 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00042440 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00042440 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00042440 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00042440 | 2 / 2 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00042440 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00042440 | 11 / 10 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00042440 | 3 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00042440 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00042440 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00042440 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00042440 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00042440 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00042440 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 0 |
P27707 | Deoxycytidine kinase | Enzyme | C00042440 | 0 / 0 |
P04183 | Thymidine kinase, cytosolic | Enzyme | C00042440 | 0 / 1 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00042440 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00042440 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00042440 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00042440 | 0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00042440 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00042440 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00042440 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00042440 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00042440 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00042440 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00042440 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00042440 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00042440 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00042440 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00042440 | 1 / 0 |
P27708 | CAD protein | Enzyme | C00019674 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00042440 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00042440 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00042440 | 4 / 1 |
P32320 | Cytidine deaminase | Enzyme | C00042440 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00042440 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00042440 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00042440 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00042440 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00042440 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00042440 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00042440 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00042440 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00042440 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00042440 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00042440 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00042440 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00042440 | 1 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00042440 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00042440 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00042440 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00042440 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00016743 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00042440 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00042440 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00042440 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00042440 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00042440 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00042440 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00042440 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00042440 | 0 / 0 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00042440 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00042440 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00042440 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00042440 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00042440 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00042440 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00042440 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00042440 | 0 / 0 |
Q9Y6Q9 | Nuclear receptor coactivator 3 | Enzyme | C00042440 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00042440 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00042440 | 1 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00042440 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00042440 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00042440 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00042440 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00042440 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00042440 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00042440 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00042440 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00042440 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00042440 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00042440 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00042440 | 0 / 0 |
O00142 | Thymidine kinase 2, mitochondrial | Enzyme | C00042440 | 1 / 1 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00042440 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00042440 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00042440 | 4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00042440 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00042440 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00042440 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00042440 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00042440 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00042440 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00042440 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00042440 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00016743 | 1 / 0 |
Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00016743 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00042440 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00042440 | 1 / 4 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00019674
C00042440
|
9154 | SLC28A1, CNT1, HCNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 1 |
C00019674
C00042440
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00019674
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00019674
|
9153 | SLC28A2, CNT2, HCNT2, HsT17153, SPNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 2 |
C00019674
|
2030 | SLC29A1, ENT1 | solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
C00019674
|
3177 | SLC29A2, DER12, ENT2, HNP36 | solute carrier family 29 (equilibrative nucleoside transporter), member 2 |
C00019674
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#609560 | Mitochondrial dna depletion syndrome 2 (myopathic type); mtdps2 |
O00142
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00469 | Mitochondrial DNA depletion syndrome (MDS) |
O00142
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04183
(marker)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D007022 | Hypotension |
C00042440
C00019674 |
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00019674
|
D000015 | Abnormalities, Multiple |
C00019674
|
D000749 | Anemia, Megaloblastic |
C00019674
|
D001919 | Bradycardia |
C00019674
|
D002375 | Catalepsy |
C00019674
|
D004342 | Drug Hypersensitivity |
C00019674
|
D056486 | Drug-Induced Liver Injury |
C00019674
|
D011041 | Poisoning |
C00016743
|
D005234 | Fatty Liver |
C00019674
|
D028361 | Mitochondrial Diseases |
C00019674
|
C538525 | Mitochondrial encephalopathy |
C00019674
|
D017240 | Mitochondrial Myopathies |
C00019674
|
D010523 | Peripheral Nervous System Diseases |
C00019674
|
D011565 | Psoriasis |
C00019674
|
D019956 | Stereotypic Movement Disorder |
C00019674
|